Overview

  • Product nameUK 14,304 tartrate
  • Description
    Selective α2 adrenergic agonist
  • Alternative names
    • Brimonidine
  • Biological descriptionFull, selective α2 agonist. Neuroprotective effects.
  • Purity> 99%

Properties

    References for UK 14,304 tartrate (ab120773)

    This product has been referenced in:
    • Lee KY  et al. Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells. Mol Vis 16:246-51 (2010). Read more (PubMed: 20161817) »
    • Wang Y  et al. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats. Brain Res 1324:64-74 (2010). Read more (PubMed: 20153300) »
    • Francis H  et al. The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats. Am J Physiol Cell Physiol 293:C1252-62 (2007). Read more (PubMed: 17634418) »
    • Chopin P  et al. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther 288:798-804 (1999). Read more (PubMed: 9918591) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120773.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"